Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cureus|September 15, 2025
Postpartum Haemorrhage Burden, Management and Challenges in Malaysia: A Scoping Review and Expert Recommendations for Effective ManagementMukhri Hamdan, Carol Lim, Boon Nee Tang, et al.Blood Research|December 21, 2025
Insights into Treatment-Free Remission (TFR) outcomes in Chronic Myeloid Leukaemia (CML) - a tertiary centre experience in MalaysiaChristopher Chin Keong Liam, Yang Liang Boo, Li Min Lim, et al.BMC Medical Genomics|January 16, 2022
Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panelJaymi Tan, Yock Ping Chow, Norziha Zainul Abidin, et al.Journal of Blood Medicine|June 28, 2022
Clinical Epidemiology, Treatment Outcome and Mortality Rate of Newly Diagnosed Immune Thrombocytopenia in Adult Multicentre Study in MalaysiaRoszymah Hamzah, Nurasyikin Yusof, Nor Rafeah Tumian, et al.The American Journal of Case Reports|March 8, 2023
Plasma Cell Leukemia with Successful Upfront Venetoclax in Combination with Allogeneic TransplantationAndy Sing Ong Tang, Asral Wirda Ahmad Asnawi, Alex Zhi Yang Koh, et al.Leukemia Research|December 28, 2025
Clinical characteristics, treatment pathway and resource utilisation for patients with chronic lymphocytic leukaemia: A multicentre retrospective studyAhmad Alhuraiji, Ayman Alhejazi, Bhausaheb Bagal, et al.Asia-Pacific Journal of Clinical Oncology|June 27, 2025
A Multicenter Real-World Study of Outcomes in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with a Polatuzumab Vedotin-Based Regimen in a Compassionate Use Program in MalaysiaS Fadilah Abdul Wahid, Nor Asiah Muhamad, Nor Azimah Ismail, et al.Advances in Therapy|April 4, 2024
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension StudyChristopher J Patriquin, Andrija Bogdanovic, Morag Griffin, et al.Advances in Therapy|July 28, 2025
Efficacy and Safety Maintained up to 3 Years in Adults with Paroxysmal Nocturnal Hemoglobinuria Receiving PegcetacoplanCarlos de Castro, Richard J Kelly, Morag Griffin, et al.Journal of Personalized Medicine|April 23, 2022
Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 CountriesBin Hashim Halim-Fikri, Carsten W Lederer, Atif Amin Baig, et al.Pageof 2